ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 31.61% of DMAC shares are held by financial institutions. ALTIUM CAPITAL MANAGEMENT LP is the top corporate investor, holding 0 shares valued at -. A 0% stake in DiaMedica Therapeutics Inc. is owned by the company. VANGUARD GROUP INC owns 1.01M shares valued at $2.81M, which translates its holding of 3.11% of the stake in the company.
Among the DMAC insiders holding of 26.22% of the stake in company, VON KOCH THOMAS, 10 percent owner, holds the largest shares of 5.53M. STAHLBERG JAN, 10 percent owner, is the second largest DMAC insider with ownership of 5.22M shares. TOMENTERPRISE AB, , stands third with possession of 2.86M shares of that stake.